Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksARL.L Regulatory News (ARL)

  • There is currently no data for ARL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Warrant Agreement

30 Mar 2005 10:22

Arlington Group Ltd30 March 2005 Arlington Group Limited ("Arlington" of the "Company") Warrant Agreement The Company has entered into an agreement with Mr Nicholas Barham, ExecutiveChairman of the Company, in order to purchase the warrant instrument granted toMr Barham on 24 September 1999 (the "Warrant"). The Warrant, which expires on 30September 2009, entitles Mr Barham to subscribe for up to 15 per cent of thefully diluted share capital of the Company as at the date of the exercise, at aprice of 50p per ordinary share of 0.5 pence in the Company ("Ordinary Share").The consideration for the Warrant will be satisfied by the issue to Mr Barham of6,371,210 new Ordinary Shares ("New Ordinary Shares") credited as fully paid A non-dilutable 15% Warrant is an unusual financial instrument for an AIM-listedcompany. The open-ended nature of the instrument creates a level of uncertaintyin the capital structure of Arlington and, in particular, the future level ofdilution to which both assets and earnings will be subject. This issue hasbecome particularly acute as the NAV per share of Arlington has grown to exceedthe exercise price of the Warrant. The effect of this uncertainty has a negativeimpact on investor sentiment and also has become an issue in negotiations withvendors of businesses where Arlington is seeking to satisfy part or all of theconsideration by the issue of securities. The agreement to cancel the warrantresolves all of these issues. Pursuant to the above, the Company has made application for the New OrdinaryShares to be admitted to trading on the Alternative Investment Market of theLondon Stock Exchange. Dealings in these shares are expected to commence on 4April 2005 ("Admission"). The New Ordinary Shares will rank pari passu with theexisting issued Ordinary Shares of the Company. Following Admission of the NewOrdinary Shares, the enlarged issued share capital of the Company will be64,923,714 Ordinary Shares Following the agreement, and Admission of the Ordinary Shares, Mr Barham willhave increased his beneficial holding from 38,810,219 Ordinary Shares to45,181,429 Ordinary Shares, representing an increase from 66.28 per cent of thecurrent issued share capital to 69.59 per cent of the enlarged issued sharecapital of the Company. Mr Barham holds no further warrants or options in theCompany. The Directors (excluding Mr Barham, who is interested in the transaction),having consulted Evolution Securities Limited, consider the terms of the WarrantAgreement to be fair and reasonable insofar as shareholders are concerned. 30 March 2005 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
3rd Sep 20079:44 amRNSEPT Disclosure
31st Aug 200711:07 amRNSRule 8.3- SMC Group Plc
31st Aug 200710:33 amRNSEPT Disclosure
30th Aug 20079:46 amRNSEPT Disclosure
29th Aug 20079:35 amRNSEPT Disclosure
23rd Aug 20079:49 amRNSEPT Disclosure
22nd Aug 200712:50 pmRNSRule 8.3- SMC Group PLC
22nd Aug 20079:58 amRNSEPT Disclosure
21st Aug 200711:22 amRNSRule 8.3- SMC Group PLC
21st Aug 20079:56 amRNSEPT Disclosure
20th Aug 200712:43 pmRNSRule 8.3- SMC Group PLC
20th Aug 200711:32 amRNSAIM Rule 26
20th Aug 20079:57 amRNSEPT Disclosure
17th Aug 20073:29 pmRNSAIM Rule 26 Information
17th Aug 20079:49 amRNSEPT Disclosure
15th Aug 200710:58 amRNSEPT Disclosure - Amendment
14th Aug 200710:08 amRNSEPT Disclosure
10th Aug 20071:53 pmRNSRule 8.3- SMC Group PLC-Amend
10th Aug 200711:38 amRNSEPT Disclosure - Amendment
10th Aug 200711:06 amRNSEPT Disclosure
9th Aug 200712:09 pmRNSRule 8.3- SMC Group PLC
9th Aug 200711:10 amRNSEPT Disclosure
8th Aug 200712:02 pmRNSPotential merger
8th Aug 200712:00 pmRNSMerger Discussions
30th Jul 200711:00 amRNSTrading Statement
26th Jul 20074:50 pmRNSExtended Seed Funding
26th Jul 20074:46 pmRNSDirector/PDMR Shareholding
12th Jul 20078:37 amRNSAdditional Listing
3rd Jul 200710:07 amRNSHolding(s) in Company
14th Jun 200711:22 amRNSAnnual Report and Accounts
12th Jun 200711:46 amRNSResult of AGM
6th Jun 20072:51 pmRNSHolding(s) in Company
6th Jun 20079:43 amRNSAdditional Listing
5th Jun 200710:38 amRNSConfirmation of AGM
31st May 20077:02 amRNSUpdate & Directorate Change
25th May 20078:20 amRNSTrading Statement
16th Apr 20077:01 amRNSContract Wins
11th Apr 20077:01 amRNSFinal Results
29th Mar 20077:03 amRNSStatement re. Results
8th Mar 20077:04 amRNSFramework Agreement
27th Feb 200711:10 amRNSHolding(s) in Company
19th Feb 20079:04 amRNSHolding(s) in Company
12th Feb 20077:02 amRNSDirectorate Change
26th Jan 20074:23 pmRNSDirector/PDMR Shareholding
26th Jan 200712:36 pmRNSDirector/PDMR Shareholding
25th Jan 20077:01 amRNSPre-close Trading Update
3rd Jan 20073:44 pmRNSTotal Voting Rights
20th Dec 20067:00 amRNSInterim Results
19th Dec 20068:10 amRNSTotal Voting Rights
14th Dec 20064:05 pmRNSDividend Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.